Advance Agrolife

Why is Advance Agrolife Ltd falling/rising?

As of 06-Aug, Advance Agrolife Ltd's stock price is at 129.60, down 3.14% after two days of gains, indicating a trend reversal. Despite recent positive performance over the week and month, today's decline may be due to profit-taking and increased selling pressure amid market volatility.

As of 06-Aug, Advance Agrolife Ltd's stock price is currently at 129.60, reflecting a decrease of 4.2 points or 3.14%. This decline comes after a period of two consecutive days of gains, indicating a trend reversal. The stock has underperformed its sector by 2.68% today, which may contribute to the current downward movement. <BR><BR>Despite this drop, the stock has shown positive performance over the past week and month, with increases of 8.91% and 12.40% respectively. However, it is important to note that the stock traded in a wide range today, reaching a high of Rs 141.7 and a low of Rs 128, suggesting volatility in trading. The weighted average price indicates that more volume was traded closer to the low price, which may reflect investor sentiment leaning towards selling.<BR><BR>Additionally, while the stock is trading above its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), the significant drop today may be influenced by profit-taking after the recent gains. The rising investor participation, evidenced by a 135.42% increase in delivery volume compared to the 5-day average, suggests that while there is interest in the stock, the current trading activity is resulting in a price decline. Overall, the combination of recent performance, market volatility, and investor behavior appears to be driving the stock's current fall.

Which are the latest news on Advance Agrolife?

Should I buy, sell or hold Advance Agrolife Ltd?

When is the next results date for Advance Agrolife Ltd?

The next results date for Advance Agrolife Ltd is August 6, 2026.

The next results date for Advance Agrolife Ltd is scheduled for August 6, 2026.

What does Advance Agrolife do?

Advance Agrolife Ltd operates in the pesticides and agrochemicals sector, reporting net sales of 124 Cr and a net profit of 7 Cr for March 2026, with a market cap of INR 651 Cr. Key metrics include a P/E ratio of 18.00 and a debt-equity ratio of 0.07.

Overview: <BR>Advance Agrolife Ltd operates in the pesticides and agrochemicals industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The incorporation year is not provided, and there are no status changes mentioned. The latest quarter for which sales and profit are reported is March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 124 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 7 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 651 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 18.00 <BR>Industry P/E: 29 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.07 <BR>Return on Equity: 11.38% <BR>Price-to-Book: 2.06 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

How big is Advance Agrolife?

As of 10th June, Advance Agrolife Ltd has a market capitalization of 651.00 Cr, with recent net sales of 637.78 Cr and a net profit of 35.29 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Advance Agrolife Ltd has a market capitalization of 651.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 637.78 Cr, while the sum of Net Profit for the same period is 35.29 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 100.87 Cr, and Total Assets amount to 350.71 Cr.

Who are the peers of the Advance Agrolife?

Advance Agrolife's peers include Astec Lifescienc, Punjab Chemicals, Meghmani Organi., Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, and Crop Life Scienc. Key insights show Dharmaj Crop has excellent management and capital structure, while Bhaskar Agrochem leads in 1-year returns at 28.03%, and Meghmani Organi. has the lowest at -49.01%.

Peers: The peers of Advance Agrolife are Astec Lifescienc, Punjab Chemicals, Meghmani Organi., Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, Crop Life Scienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dharmaj Crop and Bhaskar Agrochem, while Average management risk is found at Punjab Chemicals, Meghmani Organi., Heranba Inds, and Crop Life Scienc. Below Average management risk is noted at Astec Lifescienc, Shivalik Rasayan, and Best Agrolife. Growth is rated as Good for Dharmaj Crop, Average for Punjab Chemicals, Bhaskar Agrochem, and the rest, while Below Average growth is seen at Astec Lifescienc, Meghmani Organi., Heranba Inds, Best Agrolife, Shivalik Rasayan, and Crop Life Scienc. Capital Structure is Excellent for Dharmaj Crop and Shivalik Rasayan, Good for Punjab Chemicals, Average for Heranba Inds, Best Agrolife, and the rest, while Below Average is noted at Astec Lifescienc, Meghmani Organi., and Bhaskar Agrochem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bhaskar Agrochem at 28.03%, while Meghmani Organi. has the lowest at -49.01%. Advance Agrolife's 1-year return is not available for comparison. Additionally, several peers, including Heranba Inds, Best Agrolife, Shivalik Rasayan, and Meghmani Organi., have negative six-month returns.

Are Advance Agrolife Ltd latest results good or bad?

Advance Agrolife Ltd's latest results show strong profit growth, with a 421.68% increase in net profit for Q4 FY26, but revenue has declined sequentially, raising concerns about sustainability. Additionally, cash flow issues and reduced institutional investor participation suggest caution regarding the company's long-term prospects.

Advance Agrolife Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net profit for Q4 FY26, reaching ₹7.46 crores, which is up 421.68% year-on-year and 147.90% quarter-on-quarter. This indicates strong profitability improvement and operational efficiency, as reflected in the expansion of the PAT margin to 6.02%, up from 1.59% a year prior.<BR><BR>However, the revenue figures tell a different story. The company recorded revenue of ₹123.88 crores, which represents a robust year-on-year growth of 37.90%. Yet, it also experienced a sequential decline of 6.60% from the previous quarter, highlighting volatility in revenue generation. This inconsistency raises concerns about the sustainability of the recent profit growth.<BR><BR>Additionally, while operating margins improved to 10.80%, the company faces challenges related to cash flow generation, with operating cash flow dropping significantly to ₹5.00 crores from ₹14.00 crores in the prior year. Furthermore, there has been a notable decline in institutional investor participation, which could signal caution among sophisticated investors regarding the company's long-term prospects.<BR><BR>In summary, while the profit growth is commendable, the underlying issues with revenue consistency and cash flow generation, along with declining institutional confidence, suggest that the overall results may not be as favorable as the profit figures alone would indicate. Investors should consider these factors when evaluating the company's performance.